Similarly, transfecting B-cell lymphomas with a CD40-agonist aptamer SMG1-shRNA chimera inhibited NMD activity, due to SMG1 kinase knockdown, and improved survival of mice with B-cell lymphomas (Table 2) [144]. This evidence concerns the gene PLA1A and B-cell non-Hodgkin lymphoma.